APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alinia (nitazoxanide)

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.

Selected research

Market Analysis & Forecast

Global Alinia (nitazoxanide) Market Analysis and Forecast 2026-2032

30 December 2025192 pages

Choose your research edition.

Industry ResearchAlinia (nitazoxanide) Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Alinia (nitazoxanide) Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Alinia (nitazoxanide) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alinia (nitazoxanide) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Alinia (nitazoxanide) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.

The key players of Alinia (nitazoxanide) include Romark Laboratories, Chugai Pharmaceutical, Lupin etc. The top three players of Alinia (nitazoxanide) account for approximately 45% of the total global market. Asia-Pacific is the largest consumer market of Alinia (nitazoxanide) accounting for about 45% followed by South America and Europe. In terms of Type, Tablets is the largest segment, with a share about 99%. And in terms of Application, the largest application is Hospital followed by Retail Pharmacy.

This report presents an overview of global market for Alinia (nitazoxanide), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Alinia (nitazoxanide), also provides the sales of main regions and countries. Of the upcoming market potential for Alinia (nitazoxanide), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Alinia (nitazoxanide) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Alinia (nitazoxanide) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Alinia (nitazoxanide) sales, projected growth trends, production technology, application and end-user industry.

Alinia (nitazoxanide) Segment by Company

Romark Laboratories

Chugai Pharmaceutical

Lupin

Alinia (nitazoxanide) Segment by Type

Tablets

Oral Suspension

Alinia (nitazoxanide) Segment by Application

Retail Pharmacy

Hospital

Others

Alinia (nitazoxanide) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alinia (nitazoxanide) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alinia (nitazoxanide) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alinia (nitazoxanide).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Alinia (nitazoxanide) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Alinia (nitazoxanide) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Alinia (nitazoxanide) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Alinia (nitazoxanide) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablets Major Manufacturers Table 3. Oral Suspension Major Manufacturers Table 4. Global Alinia (nitazoxanide) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Retail Pharmacy Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Others Major Manufacturers Table 8. Alinia (nitazoxanide) Industry Trends Table 9. Alinia (nitazoxanide) Industry Drivers Table 10. Alinia (nitazoxanide) Industry Opportunities and Challenges Table 11. Alinia (nitazoxanide) Industry Restraints Table 12. Global Alinia (nitazoxanide) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Alinia (nitazoxanide) Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Alinia (nitazoxanide) Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Alinia (nitazoxanide) Revenue Market Share by Region (2021-2026) Table 16. Global Alinia (nitazoxanide) Revenue Market Share by Region (2027-2032) Table 17. Global Alinia (nitazoxanide) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Alinia (nitazoxanide) Sales by Region (2021-2026) & (K Units) Table 19. Global Alinia (nitazoxanide) Sales by Region (2027-2032) & (K Units) Table 20. Global Alinia (nitazoxanide) Sales Market Share by Region (2021-2026) Table 21. Global Alinia (nitazoxanide) Sales Market Share by Region (2027-2032) Table 22. Global Alinia (nitazoxanide) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Alinia (nitazoxanide) Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Alinia (nitazoxanide) Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Alinia (nitazoxanide) Sales Market Share by Manufacturers (2021-2026) Table 26. Global Alinia (nitazoxanide) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Alinia (nitazoxanide) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Alinia (nitazoxanide) Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Alinia (nitazoxanide) Manufacturers, Product Type & Application Table 30. Global Alinia (nitazoxanide) Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Alinia (nitazoxanide) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Alinia (nitazoxanide) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Alinia (nitazoxanide) Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Alinia (nitazoxanide) Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Alinia (nitazoxanide) Revenue Market Share by Type (2021-2026) Table 37. Global Alinia (nitazoxanide) Revenue Market Share by Type (2027-2032) Table 38. Global Alinia (nitazoxanide) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Alinia (nitazoxanide) Sales by Type (2021-2026) & (K Units) Table 40. Global Alinia (nitazoxanide) Sales by Type (2027-2032) & (K Units) Table 41. Global Alinia (nitazoxanide) Sales Market Share by Type (2021-2026) Table 42. Global Alinia (nitazoxanide) Sales Market Share by Type (2027-2032) Table 43. Global Alinia (nitazoxanide) Price by Type (2021-2026) & (US$/Unit) Table 44. Global Alinia (nitazoxanide) Price by Type (2027-2032) & (US$/Unit) Table 45. Global Alinia (nitazoxanide) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Alinia (nitazoxanide) Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Alinia (nitazoxanide) Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Alinia (nitazoxanide) Revenue Market Share by Application (2021-2026) Table 49. Global Alinia (nitazoxanide) Revenue Market Share by Application (2027-2032) Table 50. Global Alinia (nitazoxanide) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Alinia (nitazoxanide) Sales by Application (2021-2026) & (K Units) Table 52. Global Alinia (nitazoxanide) Sales by Application (2027-2032) & (K Units) Table 53. Global Alinia (nitazoxanide) Sales Market Share by Application (2021-2026) Table 54. Global Alinia (nitazoxanide) Sales Market Share by Application (2027-2032) Table 55. Global Alinia (nitazoxanide) Price by Application (2021-2026) & (US$/Unit) Table 56. Global Alinia (nitazoxanide) Price by Application (2027-2032) & (US$/Unit) Table 57. Romark Laboratories Company Information Table 58. Romark Laboratories Business Overview Table 59. Romark Laboratories Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Romark Laboratories Alinia (nitazoxanide) Product Portfolio Table 61. Romark Laboratories Recent Development Table 62. Chugai Pharmaceutical Company Information Table 63. Chugai Pharmaceutical Business Overview Table 64. Chugai Pharmaceutical Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Chugai Pharmaceutical Alinia (nitazoxanide) Product Portfolio Table 66. Chugai Pharmaceutical Recent Development Table 67. Lupin Company Information Table 68. Lupin Business Overview Table 69. Lupin Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Lupin Alinia (nitazoxanide) Product Portfolio Table 71. Lupin Recent Development Table 72. North America Alinia (nitazoxanide) Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Alinia (nitazoxanide) Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Alinia (nitazoxanide) Sales by Type (2021-2026) & (K Units) Table 75. North America Alinia (nitazoxanide) Sales by Type (2027-2032) & (K Units) Table 76. North America Alinia (nitazoxanide) Sales Price by Type (2021-2026) & (US$/Unit) Table 77. North America Alinia (nitazoxanide) Sales Price by Type (2027-2032) & (US$/Unit) Table 78. North America Alinia (nitazoxanide) Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Alinia (nitazoxanide) Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Alinia (nitazoxanide) Sales by Application (2021-2026) & (K Units) Table 81. North America Alinia (nitazoxanide) Sales by Application (2027-2032) & (K Units) Table 82. North America Alinia (nitazoxanide) Sales Price by Application (2021-2026) & (US$/Unit) Table 83. North America Alinia (nitazoxanide) Sales Price by Application (2027-2032) & (US$/Unit) Table 84. North America Alinia (nitazoxanide) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Alinia (nitazoxanide) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Alinia (nitazoxanide) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Alinia (nitazoxanide) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 88. North America Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 89. North America Alinia (nitazoxanide) Sales by Country (2027-2032) & (K Units) Table 90. North America Alinia (nitazoxanide) Sales Price by Country (2021-2026) & (US$/Unit) Table 91. North America Alinia (nitazoxanide) Sales Price by Country (2027-2032) & (US$/Unit) Table 92. United States Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 93. Canada Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 94. Mexico Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 95. Europe Alinia (nitazoxanide) Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Alinia (nitazoxanide) Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Alinia (nitazoxanide) Sales by Type (2021-2026) & (K Units) Table 98. Europe Alinia (nitazoxanide) Sales by Type (2027-2032) & (K Units) Table 99. Europe Alinia (nitazoxanide) Sales Price by Type (2021-2026) & (US$/Unit) Table 100. Europe Alinia (nitazoxanide) Sales Price by Type (2027-2032) & (US$/Unit) Table 101. Europe Alinia (nitazoxanide) Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Alinia (nitazoxanide) Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Alinia (nitazoxanide) Sales by Application (2021-2026) & (K Units) Table 104. Europe Alinia (nitazoxanide) Sales by Application (2027-2032) & (K Units) Table 105. Europe Alinia (nitazoxanide) Sales Price by Application (2021-2026) & (US$/Unit) Table 106. Europe Alinia (nitazoxanide) Sales Price by Application (2027-2032) & (US$/Unit) Table 107. Europe Alinia (nitazoxanide) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Alinia (nitazoxanide) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe Alinia (nitazoxanide) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe Alinia (nitazoxanide) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 111. Europe Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 112. Europe Alinia (nitazoxanide) Sales by Country (2027-2032) & (K Units) Table 113. Europe Alinia (nitazoxanide) Sales Price by Country (2021-2026) & (US$/Unit) Table 114. Europe Alinia (nitazoxanide) Sales Price by Country (2027-2032) & (US$/Unit) Table 115. Germany Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 116. France Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 117. U.K. Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 118. Italy Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 119. Russia Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 120. Spain Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 121. Netherlands Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 122. Switzerland Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 123. Sweden Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 124. Poland Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 125. China Alinia (nitazoxanide) Revenue by Type (2021-2026) & (US$ Million) Table 126. China Alinia (nitazoxanide) Revenue by Type (2027-2032) & (US$ Million) Table 127. China Alinia (nitazoxanide) Sales by Type (2021-2026) & (K Units) Table 128. China Alinia (nitazoxanide) Sales by Type (2027-2032) & (K Units) Table 129. China Alinia (nitazoxanide) Sales Price by Type (2021-2026) & (US$/Unit) Table 130. China Alinia (nitazoxanide) Sales Price by Type (2027-2032) & (US$/Unit) Table 131. China Alinia (nitazoxanide) Revenue by Application (2021-2026) & (US$ Million) Table 132. China Alinia (nitazoxanide) Revenue by Application (2027-2032) & (US$ Million) Table 133. China Alinia (nitazoxanide) Sales by Application (2021-2026) & (K Units) Table 134. China Alinia (nitazoxanide) Sales by Application (2027-2032) & (K Units) Table 135. China Alinia (nitazoxanide) Sales Price by Application (2021-2026) & (US$/Unit) Table 136. China Alinia (nitazoxanide) Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Asia Alinia (nitazoxanide) Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Alinia (nitazoxanide) Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Alinia (nitazoxanide) Sales by Type (2021-2026) & (K Units) Table 140. Asia Alinia (nitazoxanide) Sales by Type (2027-2032) & (K Units) Table 141. Asia Alinia (nitazoxanide) Sales Price by Type (2021-2026) & (US$/Unit) Table 142. Asia Alinia (nitazoxanide) Sales Price by Type (2027-2032) & (US$/Unit) Table 143. Asia Alinia (nitazoxanide) Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Alinia (nitazoxanide) Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Alinia (nitazoxanide) Sales by Application (2021-2026) & (K Units) Table 146. Asia Alinia (nitazoxanide) Sales by Application (2027-2032) & (K Units) Table 147. Asia Alinia (nitazoxanide) Sales Price by Application (2021-2026) & (US$/Unit) Table 148. Asia Alinia (nitazoxanide) Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia Alinia (nitazoxanide) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Alinia (nitazoxanide) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Asia Alinia (nitazoxanide) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Asia Alinia (nitazoxanide) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 153. Asia Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 154. Asia Alinia (nitazoxanide) Sales by Country (2027-2032) & (K Units) Table 155. Asia Alinia (nitazoxanide) Sales Price by Country (2021-2026) & (US$/Unit) Table 156. Asia Alinia (nitazoxanide) Sales Price by Country (2027-2032) & (US$/Unit) Table 157. Japan Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 158. South Korea Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 159. India Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 160. Australia Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 161. Taiwan Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 162. Southeast Asia Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 163. SAMEA Alinia (nitazoxanide) Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Alinia (nitazoxanide) Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Alinia (nitazoxanide) Sales by Type (2021-2026) & (K Units) Table 166. SAMEA Alinia (nitazoxanide) Sales by Type (2027-2032) & (K Units) Table 167. SAMEA Alinia (nitazoxanide) Sales Price by Type (2021-2026) & (US$/Unit) Table 168. SAMEA Alinia (nitazoxanide) Sales Price by Type (2027-2032) & (US$/Unit) Table 169. SAMEA Alinia (nitazoxanide) Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Alinia (nitazoxanide) Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Alinia (nitazoxanide) Sales by Application (2021-2026) & (K Units) Table 172. SAMEA Alinia (nitazoxanide) Sales by Application (2027-2032) & (K Units) Table 173. SAMEA Alinia (nitazoxanide) Sales Price by Application (2021-2026) & (US$/Unit) Table 174. SAMEA Alinia (nitazoxanide) Sales Price by Application (2027-2032) & (US$/Unit) Table 175. SAMEA Alinia (nitazoxanide) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. SAMEA Alinia (nitazoxanide) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. SAMEA Alinia (nitazoxanide) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. SAMEA Alinia (nitazoxanide) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. SAMEA Alinia (nitazoxanide) Sales by Country (2021-2026) & (K Units) Table 180. SAMEA Alinia (nitazoxanide) Sales by Country (2027-2032) & (K Units) Table 181. SAMEA Alinia (nitazoxanide) Sales Price by Country (2021-2026) & (US$/Unit) Table 182. SAMEA Alinia (nitazoxanide) Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Brazil Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 184. Argentina Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 185. Chile Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 186. Colombia Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 187. Peru Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 188. Saudi Arabia Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 189. Israel Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 190. UAE Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 191. Turkey Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 192. Iran Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 193. Egypt Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Alinia (nitazoxanide) Distributors List Table 197. Alinia (nitazoxanide) Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Alinia (nitazoxanide) Image Figure 2. Global Alinia (nitazoxanide) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alinia (nitazoxanide) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablets Image Figure 5. Oral Suspension Image Figure 6. Global Alinia (nitazoxanide) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Alinia (nitazoxanide) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Retail Pharmacy Image Figure 9. Hospital Image Figure 10. Others Image Figure 11. Global Alinia (nitazoxanide) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Alinia (nitazoxanide) Revenue (2021-2032) & (US$ Million) Figure 13. Global Alinia (nitazoxanide) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Alinia (nitazoxanide) Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Alinia (nitazoxanide) Revenue Market Share by Region (2021-2032) Figure 16. Global Alinia (nitazoxanide) Sales (2021-2032) & (K Units) Figure 17. Global Alinia (nitazoxanide) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Alinia (nitazoxanide) Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Alinia (nitazoxanide) Sales YoY (2021-2032) & (K Units) Figure 20. Europe Alinia (nitazoxanide) Sales YoY (2021-2032) & (K Units) Figure 21. China Alinia (nitazoxanide) Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Alinia (nitazoxanide) Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Alinia (nitazoxanide) Sales YoY (2021-2032) & (K Units) Figure 24. Global Alinia (nitazoxanide) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Alinia (nitazoxanide) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Alinia (nitazoxanide) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Alinia (nitazoxanide) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Alinia (nitazoxanide) Revenue Market Share by Type (2021-2032) Figure 30. Global Alinia (nitazoxanide) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Alinia (nitazoxanide) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Alinia (nitazoxanide) Sales Market Share by Type (2021-2032) Figure 33. Global Alinia (nitazoxanide) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Alinia (nitazoxanide) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Alinia (nitazoxanide) Revenue Market Share by Application (2021-2032) Figure 36. Global Alinia (nitazoxanide) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Alinia (nitazoxanide) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Alinia (nitazoxanide) Sales Market Share by Application (2021-2032) Figure 39. North America Alinia (nitazoxanide) Revenue Share by Type (2021-2032) Figure 40. North America Alinia (nitazoxanide) Sales Share by Type (2021-2032) Figure 41. North America Alinia (nitazoxanide) Revenue Share by Application (2021-2032) Figure 42. North America Alinia (nitazoxanide) Sales Share by Application (2021-2032) Figure 43. North America Alinia (nitazoxanide) Revenue Share by Country (2021-2032) Figure 44. North America Alinia (nitazoxanide) Sales Share by Country (2021-2032) Figure 45. Europe Alinia (nitazoxanide) Revenue Share by Type (2021-2032) Figure 46. Europe Alinia (nitazoxanide) Sales Share by Type (2021-2032) Figure 47. Europe Alinia (nitazoxanide) Revenue Share by Application (2021-2032) Figure 48. Europe Alinia (nitazoxanide) Sales Share by Application (2021-2032) Figure 49. Europe Alinia (nitazoxanide) Revenue Share by Country (2021-2032) Figure 50. Europe Alinia (nitazoxanide) Sales Share by Country (2021-2032) Figure 51. China Alinia (nitazoxanide) Revenue Share by Type (2021-2032) Figure 52. China Alinia (nitazoxanide) Sales Share by Type (2021-2032) Figure 53. China Alinia (nitazoxanide) Revenue Share by Application (2021-2032) Figure 54. China Alinia (nitazoxanide) Sales Share by Application (2021-2032) Figure 55. Asia Alinia (nitazoxanide) Revenue Share by Type (2021-2032) Figure 56. Asia Alinia (nitazoxanide) Sales Share by Type (2021-2032) Figure 57. Asia Alinia (nitazoxanide) Revenue Share by Application (2021-2032) Figure 58. Asia Alinia (nitazoxanide) Sales Share by Application (2021-2032) Figure 59. Asia Alinia (nitazoxanide) Revenue Share by Country (2021-2032) Figure 60. Asia Alinia (nitazoxanide) Sales Share by Country (2021-2032) Figure 61. SAMEA Alinia (nitazoxanide) Revenue Share by Type (2021-2032) Figure 62. SAMEA Alinia (nitazoxanide) Sales Share by Type (2021-2032) Figure 63. SAMEA Alinia (nitazoxanide) Revenue Share by Application (2021-2032) Figure 64. SAMEA Alinia (nitazoxanide) Sales Share by Application (2021-2032) Figure 65. SAMEA Alinia (nitazoxanide) Revenue Share by Country (2021-2032) Figure 66. SAMEA Alinia (nitazoxanide) Sales Share by Country (2021-2032) Figure 67. Alinia (nitazoxanide) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Alinia (nitazoxanide) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Oral Suspension
Applications
  • Retail Pharmacy
  • Hospital
  • Others
Companies covered
  • Romark Laboratories
  • Chugai Pharmaceutical
  • Lupin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Alinia (nitazoxanide) Market by Type
  3. 1.2.1 Global Alinia (nitazoxanide) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablets
  5. 1.2.3 Oral Suspension
  6. 1.3 Alinia (nitazoxanide) Market by Application
  7. 1.3.1 Global Alinia (nitazoxanide) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacy
  9. 1.3.3 Hospital
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Alinia (nitazoxanide) Market Dynamics
  1. 2.1 Alinia (nitazoxanide) Industry Trends
  2. 2.2 Alinia (nitazoxanide) Industry Drivers
  3. 2.3 Alinia (nitazoxanide) Industry Opportunities and Challenges
  4. 2.4 Alinia (nitazoxanide) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Alinia (nitazoxanide) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Alinia (nitazoxanide) Revenue by Region
  3. 3.2.1 Global Alinia (nitazoxanide) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Alinia (nitazoxanide) Revenue by Region (2021-2026)
  5. 3.2.3 Global Alinia (nitazoxanide) Revenue by Region (2027-2032)
  6. 3.2.4 Global Alinia (nitazoxanide) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Alinia (nitazoxanide) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Alinia (nitazoxanide) Sales by Region
  9. 3.4.1 Global Alinia (nitazoxanide) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Alinia (nitazoxanide) Sales by Region (2021-2026)
  11. 3.4.3 Global Alinia (nitazoxanide) Sales by Region (2027-2032)
  12. 3.4.4 Global Alinia (nitazoxanide) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Alinia (nitazoxanide) Revenue by Manufacturers
  2. 4.1.1 Global Alinia (nitazoxanide) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Alinia (nitazoxanide) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Alinia (nitazoxanide) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Alinia (nitazoxanide) Sales by Manufacturers
  6. 4.2.1 Global Alinia (nitazoxanide) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Alinia (nitazoxanide) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Alinia (nitazoxanide) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Alinia (nitazoxanide) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Alinia (nitazoxanide) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Alinia (nitazoxanide) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Alinia (nitazoxanide) Manufacturers, Product Type & Application
  13. 4.7 Global Alinia (nitazoxanide) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Alinia (nitazoxanide) Market CR5 and HHI
  16. 4.8.2 2025 Alinia (nitazoxanide) Tier 1, Tier 2, and Tier 3
5 Alinia (nitazoxanide) Market by Type
  1. 5.1 Global Alinia (nitazoxanide) Revenue by Type
  2. 5.1.1 Global Alinia (nitazoxanide) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Alinia (nitazoxanide) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Alinia (nitazoxanide) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Alinia (nitazoxanide) Sales by Type
  6. 5.2.1 Global Alinia (nitazoxanide) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Alinia (nitazoxanide) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Alinia (nitazoxanide) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Alinia (nitazoxanide) Price by Type
6 Alinia (nitazoxanide) Market by Application
  1. 6.1 Global Alinia (nitazoxanide) Revenue by Application
  2. 6.1.1 Global Alinia (nitazoxanide) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Alinia (nitazoxanide) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Alinia (nitazoxanide) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Alinia (nitazoxanide) Sales by Application
  6. 6.2.1 Global Alinia (nitazoxanide) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Alinia (nitazoxanide) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Alinia (nitazoxanide) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Alinia (nitazoxanide) Price by Application
7 Company Profiles
  1. 7.1 Romark Laboratories
  2. 7.1.1 Romark Laboratories Company Information
  3. 7.1.2 Romark Laboratories Business Overview
  4. 7.1.3 Romark Laboratories Alinia (nitazoxanide) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Romark Laboratories Alinia (nitazoxanide) Product Portfolio
  6. 7.1.5 Romark Laboratories Recent Developments
  7. 7.2 Chugai Pharmaceutical
  8. 7.2.1 Chugai Pharmaceutical Company Information
  9. 7.2.2 Chugai Pharmaceutical Business Overview
  10. 7.2.3 Chugai Pharmaceutical Alinia (nitazoxanide) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Chugai Pharmaceutical Alinia (nitazoxanide) Product Portfolio
  12. 7.2.5 Chugai Pharmaceutical Recent Developments
  13. 7.3 Lupin
  14. 7.3.1 Lupin Company Information
  15. 7.3.2 Lupin Business Overview
  16. 7.3.3 Lupin Alinia (nitazoxanide) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Lupin Alinia (nitazoxanide) Product Portfolio
  18. 7.3.5 Lupin Recent Developments
8 North America
  1. 8.1 North America Alinia (nitazoxanide) Market Size by Type
  2. 8.1.1 North America Alinia (nitazoxanide) Revenue by Type (2021-2032)
  3. 8.1.2 North America Alinia (nitazoxanide) Sales by Type (2021-2032)
  4. 8.1.3 North America Alinia (nitazoxanide) Price by Type (2021-2032)
  5. 8.2 North America Alinia (nitazoxanide) Market Size by Application
  6. 8.2.1 North America Alinia (nitazoxanide) Revenue by Application (2021-2032)
  7. 8.2.2 North America Alinia (nitazoxanide) Sales by Application (2021-2032)
  8. 8.2.3 North America Alinia (nitazoxanide) Price by Application (2021-2032)
  9. 8.3 North America Alinia (nitazoxanide) Market Size by Country
  10. 8.3.1 North America Alinia (nitazoxanide) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Alinia (nitazoxanide) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Alinia (nitazoxanide) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Alinia (nitazoxanide) Market Size by Type
  2. 9.1.1 Europe Alinia (nitazoxanide) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Alinia (nitazoxanide) Sales by Type (2021-2032)
  4. 9.1.3 Europe Alinia (nitazoxanide) Price by Type (2021-2032)
  5. 9.2 Europe Alinia (nitazoxanide) Market Size by Application
  6. 9.2.1 Europe Alinia (nitazoxanide) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Alinia (nitazoxanide) Sales by Application (2021-2032)
  8. 9.2.3 Europe Alinia (nitazoxanide) Price by Application (2021-2032)
  9. 9.3 Europe Alinia (nitazoxanide) Market Size by Country
  10. 9.3.1 Europe Alinia (nitazoxanide) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Alinia (nitazoxanide) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Alinia (nitazoxanide) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Alinia (nitazoxanide) Market Size by Type
  2. 10.1.1 China Alinia (nitazoxanide) Revenue by Type (2021-2032)
  3. 10.1.2 China Alinia (nitazoxanide) Sales by Type (2021-2032)
  4. 10.1.3 China Alinia (nitazoxanide) Price by Type (2021-2032)
  5. 10.2 China Alinia (nitazoxanide) Market Size by Application
  6. 10.2.1 China Alinia (nitazoxanide) Revenue by Application (2021-2032)
  7. 10.2.2 China Alinia (nitazoxanide) Sales by Application (2021-2032)
  8. 10.2.3 China Alinia (nitazoxanide) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Alinia (nitazoxanide) Market Size by Type
  2. 11.1.1 Asia Alinia (nitazoxanide) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Alinia (nitazoxanide) Sales by Type (2021-2032)
  4. 11.1.3 Asia Alinia (nitazoxanide) Price by Type (2021-2032)
  5. 11.2 Asia Alinia (nitazoxanide) Market Size by Application
  6. 11.2.1 Asia Alinia (nitazoxanide) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Alinia (nitazoxanide) Sales by Application (2021-2032)
  8. 11.2.3 Asia Alinia (nitazoxanide) Price by Application (2021-2032)
  9. 11.3 Asia Alinia (nitazoxanide) Market Size by Country
  10. 11.3.1 Asia Alinia (nitazoxanide) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Alinia (nitazoxanide) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Alinia (nitazoxanide) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Alinia (nitazoxanide) Market Size by Type
  2. 12.1.1 SAMEA Alinia (nitazoxanide) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Alinia (nitazoxanide) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Alinia (nitazoxanide) Price by Type (2021-2032)
  5. 12.2 SAMEA Alinia (nitazoxanide) Market Size by Application
  6. 12.2.1 SAMEA Alinia (nitazoxanide) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Alinia (nitazoxanide) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Alinia (nitazoxanide) Price by Application (2021-2032)
  9. 12.3 SAMEA Alinia (nitazoxanide) Market Size by Country
  10. 12.3.1 SAMEA Alinia (nitazoxanide) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Alinia (nitazoxanide) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Alinia (nitazoxanide) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Alinia (nitazoxanide) Value Chain Analysis
  2. 13.1.1 Alinia (nitazoxanide) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Alinia (nitazoxanide) Production Mode & Process
  6. 13.2 Alinia (nitazoxanide) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Alinia (nitazoxanide) Distributors
  9. 13.2.3 Alinia (nitazoxanide) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst